Skip to main content

Arsenal batch 11

Thyroid function testing: TSH, free T4 and results explained

TSH is the usual first test for suspected primary thyroid dysfunction, followed by free T4—and free T3 when TSH is low—according to the pattern. Symptoms are nonspecific, one mildly abnormal result can normalize, and high-dose biotin or acute illness can distort interpretation. Testing should answer a clinical question, not chase an ideal TSH.

Published by LongevityMate Editorial Team · Updated 2026-08-21 · 15 minute read

One-minute decision guide

The simple evidence-based protocol

Test when symptoms, medicines, pregnancy planning, examination or risk factors create a real question. For most adults without suspected pituitary disease, start with TSH; if high, add free T4, and if low, add free T4 and free T3. Tell the laboratory about biotin supplements and follow its pause instructions. Repeat a mild unexpected abnormality after enough time—often at least 6 weeks, depending on context—before labeling chronic disease. Urgent symptoms or extreme results need faster clinical care.See reference 1,See reference 2,See reference 3

Clinician reviewing TSH and free T4 laboratory trends beside a thyroid anatomy model
On this page

One-minute decision guide

The simple evidence-based protocol

Test when symptoms, medicines, pregnancy planning, examination or risk factors create a real question. For most adults without suspected pituitary disease, start with TSH; if high, add free T4, and if low, add free T4 and free T3. Tell the laboratory about biotin supplements and follow its pause instructions. Repeat a mild unexpected abnormality after enough time—often at least 6 weeks, depending on context—before labeling chronic disease. Urgent symptoms or extreme results need faster clinical care.See reference 1,See reference 2,See reference 3

The 10 rules to remember

First principles: what this can actually change

The pituitary senses circulating thyroid hormone and changes TSH, making TSH a sensitive signal of primary thyroid-gland dysfunction.See reference 1,See reference 2

Free T4 shows available circulating thyroxine and helps distinguish overt from subclinical patterns. Pituitary disease can break the usual TSH logic, so both tests are needed when suspected.See reference 3,See reference 4

Reference ranges describe populations, not a personal optimization target. Treatment is justified by persistent biochemical disease, symptoms, risk and context—not by moving every value to the middle.See reference 5,See reference 6

A practical decision protocol

Stage
1. Define indication
What to do
Review symptoms, examination, medicines, pregnancy and risk
Why it matters
Avoids low-value screeningSee reference 1,See reference 2
Stage
2. Order correctly
What to do
Use TSH with reflex free T4/T3 or a clinically appropriate panel
Why it matters
Matches the feedback physiologySee reference 2,See reference 3
Stage
3. Remove interference
What to do
Report biotin, acute illness and relevant medicines
Why it matters
Prevents false patternsSee reference 3,See reference 4
Stage
4. Confirm and act
What to do
Repeat or investigate according to severity and context
Why it matters
One mild result is not always diseaseSee reference 4,See reference 5

Timing and frequency

Decision
Routine suspected primary disease
Practical answer
Begin with TSH; use reflex free T4 and free T3 according to the result.See reference 3,See reference 4
Decision
Mild unexpected abnormality
Practical answer
Repeat after at least 6 weeks or a clinician-defined interval once transient factors settle.See reference 4,See reference 5
Decision
After levothyroxine change
Practical answer
TSH is commonly reviewed after roughly 6–8 weeks because steady state takes time.See reference 5,See reference 6
Decision
Pregnancy or severe symptoms
Practical answer
Use faster, specialist-guided timing and pregnancy-specific ranges.See reference 6,See reference 7

What to measure

Signal
TSH
How
Interpret with the laboratory range and clinical context
Interpretation
High usually suggests primary underactivity; low suggests excess, but exceptions existSee reference 4,See reference 5
Signal
Free T4
How
Pair with TSH
Interpretation
Separates overt from subclinical patterns and helps detect central diseaseSee reference 5,See reference 6
Signal
Free T3
How
Use mainly with low TSH or suspected hyperthyroidism
Interpretation
Can detect T3-predominant excessSee reference 6,See reference 7
Signal
Thyroid antibodies
How
Order when the cause or future risk matters
Interpretation
Support autoimmunity but do not measure symptom severitySee reference 7,See reference 8

What the evidence actually shows

Guidelines support a cascade approach that starts with TSH for most adults and adds thyroid hormones according to the result.See reference 1,See reference 3

Testing is valuable for symptomatic or higher-risk people, but USPSTF finds insufficient evidence that universal screening of asymptomatic nonpregnant adults improves outcomes.See reference 4,See reference 6

Levothyroxine is established treatment for overt primary hypothyroidism; benefit for mild subclinical disease is smaller and depends on TSH level, symptoms, age, pregnancy and risk.See reference 7,See reference 8

Evidence strength by claim

Claim
TSH plus free T4 diagnoses primary thyroid dysfunction
Confidence
High
Important boundary
Pituitary disease and acute illness need different interpretationSee reference 1,See reference 2
Claim
Treating overt hypothyroidism
Confidence
High
Important boundary
Dose and monitoring are individualizedSee reference 3,See reference 4
Claim
Universal screening of asymptomatic adults
Confidence
Low
Important boundary
Outcome benefit remains insufficientSee reference 5,See reference 6
Claim
Reverse T3 guides routine treatment
Confidence
Low
Important boundary
Not clinically useful in healthy outpatientsSee reference 7,See reference 8,See reference 9

Limits and common overclaims

Fatigue, weight change, hair loss, anxiety and temperature sensitivity have many causes; symptoms alone are not diagnostic.See reference 3,See reference 7

Acute illness and medicines can create non-thyroidal patterns that should not trigger reflex long-term treatment.See reference 5,See reference 8

High-dose biotin can produce falsely high or low immunoassay results, so supplement disclosure is part of test quality.See reference 9,See reference 10

A four-step implementation plan

  • 1. Review symptoms, examination, medicines, pregnancy and riskSee reference 1
  • 2. Use TSH with reflex free T4/T3 or a clinically appropriate panelSee reference 2
  • 3. Report biotin, acute illness and relevant medicinesSee reference 3
  • 4. Repeat or investigate according to severity and contextSee reference 4

Troubleshooting

Problem
High TSH with normal free T4
Likely issue
Possible subclinical hypothyroidism or transient change
Better next step
Repeat, review antibodies and decide by level, symptoms and riskSee reference 2,See reference 3
Problem
Low TSH with normal hormones
Likely issue
Possible subclinical hyperthyroidism, medicine or interference
Better next step
Repeat and assess cause, heart and bone riskSee reference 4,See reference 5
Problem
Symptoms despite normal tests
Likely issue
Another cause may be responsible
Better next step
Broaden evaluation rather than escalating thyroid hormoneSee reference 6,See reference 7
Problem
Results conflict with the clinical picture
Likely issue
Assay interference, pituitary disease or illness may be present
Better next step
Discuss repeat testing or specialist laboratory reviewSee reference 8,See reference 9

Safety and when to get medical help

Seek urgent care for severe chest pain, fainting, marked breathlessness, confusion, very rapid or irregular heartbeat, severe weakness or symptoms of thyroid storm or myxedema. Pregnancy, pituitary disease, amiodarone or lithium use, thyroid nodules, major heart disease and extreme TSH or hormone values need clinician-led interpretation.See reference 1,See reference 5,See reference 9

Who is most likely to benefit

People with compatible symptoms, goiter, thyroid nodules, autoimmune disease, relevant medicines or strong family history.See reference 2,See reference 4

People planning pregnancy or pregnant, using pregnancy-specific guidance.See reference 5,See reference 7

Patients already treated for thyroid disease who need dose and safety monitoring—not frequent testing without a treatment decision.See reference 8,See reference 10

Track five things

Frequently asked questions

What is the best first thyroid test?

TSH is usually first for suspected primary thyroid disease, with free T4 added according to the result.See reference 1

What does high TSH mean?

It often indicates an underactive thyroid, but free T4, persistence and context determine whether disease is overt or subclinical.See reference 2

What does low TSH mean?

It can indicate thyroid hormone excess, over-replacement, medicine effects, illness or assay interference.See reference 3

Should I test free T3?

It is useful mainly when TSH is low or hyperthyroidism is suspected; it is rarely helpful for routine hypothyroidism.See reference 4

Do I need reverse T3?

No. It is not clinically useful for diagnosing routine hypothyroidism in healthy outpatients.See reference 5

Can biotin affect results?

Yes. High-dose biotin can distort some assays; ask the laboratory how long to pause it.See reference 6

Should everyone be screened?

USPSTF finds insufficient evidence for universal screening of asymptomatic nonpregnant adults.See reference 7

How soon after a dose change should I retest?

Often about 6–8 weeks for levothyroxine, but follow the prescriber's plan.See reference 8

Connect this decision to your wider health picture

LongevityMate helps organize measurements, symptoms, habits and trends so a test or treatment stays in context instead of becoming the whole plan.

See how LongevityMate works

References

  1. 1. Thyroid Disease: Assessment and Management

    NICEGuideline

  2. 2. Thyroid Dysfunction: Screening

    U.S. Preventive Services Task ForceGuideline

  3. 3. Thyroid Function Tests

    American Thyroid AssociationOfficial guidance

  4. 4. Guidelines for Treatment of Hypothyroidism

    American Thyroid AssociationGuideline

  5. 5. Hypothyroidism in Adults Guideline

    AACE and American Thyroid AssociationGuideline

  6. 6. Biotin Interference in Laboratory Tests

    U.S. Food and Drug AdministrationOfficial guidance

  7. 7. Thyroid Hormone Therapy for Subclinical Hypothyroidism

    JAMAMeta-analysis

  8. 8. TRUST Trial of Thyroxine in Older Adults

    New England Journal of MedicineRandomized trial

  9. 9. Subclinical Hyperthyroidism and Cardiovascular Outcomes

    Archives of Internal MedicineObservational study

  10. 10. Thyroid Testing in Acute Illness

    Clinical MedicineEvidence review

Editorial transparency

Published by
LongevityMate Editorial Team
Published
Updated

Medical disclaimer

This guide provides general health education. It does not diagnose a condition, prescribe treatment, replace individualized medical care, or guarantee a health or longevity outcome.